374 related articles for article (PubMed ID: 31388779)
21. Sacral Neuromodulation: Device Improvement and Current Applications in Urology.
Spilotros M; Gerbasi S; Lasorsa F; de Rienzo G; Balducci L; Ditonno P; Lucarelli G
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541235
[TBL] [Abstract][Full Text] [Related]
22. Sacral neuromodulation with implanted devices for urinary storage and voiding dysfunction in adults.
Herbison GP; Arnold EP
Cochrane Database Syst Rev; 2009 Apr; (2):CD004202. PubMed ID: 19370596
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous tibial nerve stimulation for the treatment of voiding dysfunction.
Technol Eval Cent Assess Program Exec Summ; 2011 Mar; 25(8):1-7. PubMed ID: 21638944
[No Abstract] [Full Text] [Related]
24. Tibial Nerve Stimulation for Urge Urinary Incontinence and Overactive Bladder: Narrative Review of Randomized Controlled Trials and Applicability to Implantable Devices.
Lee UJ; MacDiarmid S; Matthews CA; Gillespie E; Peters KM
Adv Ther; 2024 Jul; 41(7):2635-2654. PubMed ID: 38748331
[TBL] [Abstract][Full Text] [Related]
25. Sacral Neuromodulation for Genitourinary Problems.
Banakhar M; Hassouna M
Prog Neurol Surg; 2015; 29():192-9. PubMed ID: 26394134
[TBL] [Abstract][Full Text] [Related]
26. Prolonged percutaneous SNM testing does not cause infection-related explanation.
Marks BK; Vasavada SP
BJU Int; 2013 Mar; 111(3):368. PubMed ID: 22738360
[No Abstract] [Full Text] [Related]
27. [Therapeutic value of neuromodulation in women].
van Ophoven A
Urologie; 2023 Feb; 62(2):153-164. PubMed ID: 36690725
[TBL] [Abstract][Full Text] [Related]
28. Cost profiles and budget impact of rechargeable versus non-rechargeable sacral neuromodulation devices in the treatment of overactive bladder syndrome.
Noblett KL; Dmochowski RR; Vasavada SP; Garner AM; Liu S; Pietzsch JB
Neurourol Urodyn; 2017 Mar; 36(3):727-733. PubMed ID: 27062384
[TBL] [Abstract][Full Text] [Related]
29. The value of urodynamic tools to guide patient selection in sacral neuromodulation.
Drossaerts J; Rademakers K; van Koeveringe G; Van Kerrebroeck P
World J Urol; 2015 Nov; 33(11):1889-95. PubMed ID: 25680936
[TBL] [Abstract][Full Text] [Related]
30. Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects.
Tilborghs S; De Wachter S
Expert Rev Med Devices; 2022 Feb; 19(2):161-187. PubMed ID: 35061951
[TBL] [Abstract][Full Text] [Related]
31. An overview of sacral neuromodulation: a treatment for patients with symptoms of lower urinary tract dysfunction.
Fletcher N
Br J Nurs; 2020 Aug; 29(15):848-856. PubMed ID: 32790556
[TBL] [Abstract][Full Text] [Related]
32. Remotely programmed sacral neuromodulation for the treatment of patients with refractory overactive bladder: a prospective randomized controlled trial evaluating the safety and efficacy of a novel sacral neuromodulation device.
Zhang Y; Zhang P; Tian X; Chen G; Li Y; Zhang Y; Xu Z; Wei Z; Zhang W; Ma L; Shi B; Liao L; Wang J
World J Urol; 2019 Nov; 37(11):2481-2492. PubMed ID: 30809700
[TBL] [Abstract][Full Text] [Related]
33. Cortical, Spinal, Sacral, and Peripheral Neuromodulations as Therapeutic Approaches for the Treatment of Lower Urinary Tract Symptoms in Multiple Sclerosis Patients: A Review.
Pericolini M; Miget G; Hentzen C; Finazzi Agrò E; Chesnel C; Lagnau P; Haddad R; Grasland M; Amarenco G
Neuromodulation; 2022 Dec; 25(8):1065-1075. PubMed ID: 34496454
[TBL] [Abstract][Full Text] [Related]
34. Sacral neuromodulation for treating the symptoms of overactive bladder syndrome and non-obstructive urinary retention: >10 years of clinical experience.
Chartier-Kastler E
BJU Int; 2008 Feb; 101(4):417-23. PubMed ID: 18070181
[No Abstract] [Full Text] [Related]
35. Neuromodulation for the Treatment of Lower Urinary Tract Symptoms.
Yamanishi T; Kaga K; Fuse M; Shibata C; Uchiyama T
Low Urin Tract Symptoms; 2015 Sep; 7(3):121-32. PubMed ID: 26663726
[TBL] [Abstract][Full Text] [Related]
36. A novel leadless, miniature implantable Tibial Nerve Neuromodulation System for the management of overactive bladder complaints.
Heesakkers JPFA; Digesu GA; van Breda J; Van Kerrebroeck P; Elneil S
Neurourol Urodyn; 2018 Mar; 37(3):1060-1067. PubMed ID: 28892221
[TBL] [Abstract][Full Text] [Related]
37. New Devices and Technologies for the Management of Overactive Bladder.
Guzman-Negron JM; Goldman HB
Curr Urol Rep; 2017 Oct; 18(12):94. PubMed ID: 29046985
[TBL] [Abstract][Full Text] [Related]
38. Sensing in Sacral Neuromodulation: A Feasibility Study in Subjects With Urinary Incontinence and Retention.
Goudelocke C; Jungbauer Nikolas LM; Bittner KC; Offutt SJ; Miller AE; Slopsema JP
Neuromodulation; 2024 Feb; 27(2):392-398. PubMed ID: 37589643
[TBL] [Abstract][Full Text] [Related]
39. Specific Changes in Brain Activity during Urgency in Women with Overactive Bladder after Successful Sacral Neuromodulation: A Functional Magnetic Resonance Imaging Study.
Weissbart SJ; Bhavsar R; Rao H; Wein AJ; Detre JA; Arya LA; Smith AL
J Urol; 2018 Aug; 200(2):382-388. PubMed ID: 29630979
[TBL] [Abstract][Full Text] [Related]
40. Randomized prospective crossover study of interstim lead wire placement with curved versus straight stylet.
Jacobs SA; Lane FL; Osann KE; Noblett KL
Neurourol Urodyn; 2014 Jun; 33(5):488-92. PubMed ID: 23737158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
